Kiromic Biopharma, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
KRBPQ, KRBP on OTC
Location
7707 Fannin St., Suite 140, Houston, TX

There are no Buy or Sell transactions made by insiders since 10/11/2024

Kiromic Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Maurizio Chiriva CHIEF EXECUTIVE OFFICER, Director $5.1M Sep 9, 2021
Scott Dahlbeck Chief of Staff $1.84M Aug 11, 2022
Gianluca Rotino CHIEF STRAT & INNOV OFFICER, Director $1.04M Jun 22, 2021
Pietro Bersani Chief Executive Officer, Director $517K Aug 23, 2024
Daniel Clark Chief Financial Officer $341K Aug 11, 2022
Michael Ryan Chief Bioinformatics Research Officer $304K Jul 12, 2021
Michael Nagel Director $211K Jun 11, 2024
Brian Hungerford Chief Financial Officer $143K Aug 19, 2024
Pamela Misajon Director $121K Jun 12, 2024
Ignacio Nunez Chief Operat. And Manuf. Offi. $65.5K Jun 22, 2021
Michael Catlin Director $27.7K Mar 18, 2024
Jerry Schneider Director $18.5K May 24, 2021
Americo Cicchetti Director Jun 30, 2022
Leonardo Mirandola Cso May 3, 2024
Shannon Ralston 10%+ Owner Jun 3, 2024
Karen Reeves Director Jun 30, 2022
Francis X. Tirelli Director Jun 30, 2022

Recent Insider Transactions by Companies or Individuals for Kiromic Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.